Unclaimed brand
Learn about KADCYLA® (ado-trastuzumab emtansine), a treatment for certain patients with early or metastatic HER2+ breast cancer. See Full Safety and Boxed Warnings for more information.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#565656
Scorpion
86, 86, 86
0, 0, 34
0, 0, 0, 66
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#692027
Crown of Thorns
105, 32, 39
354, 53, 27
0, 70, 63, 59
KADCYLA® (ado-trastuzumab emtansine) is a prescription medicine for adults with HER2-positive breast cancer. It is used after surgery for early breast cancer when cancer remains in tissue removed during surgery following neoadjuvant treatment with a taxane and trastuzumab. It is also used for metastatic breast cancer that has spread to other parts of the body after prior treatment with trastuzumab and a taxane. Patients are selected for treatment using an FDA-authorized test.
KADCYLA combines trastuzumab, which binds to HER2 proteins on cancer cells, with the chemotherapy agent emtansine. It is administered by a healthcare provider as an intravenous infusion every three weeks. Treatment for early breast cancer typically consists of 14 doses, while treatment for metastatic disease generally continues until the cancer returns or side effects require stopping.
KADCYLA can cause serious side effects, including liver and heart problems, severe bleeding, lung problems, low platelet counts, nerve damage, and harm to an unborn baby. Regular monitoring is necessary, and patients should discuss side effects with their healthcare provider.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
How do I download the KADCYLA logo?
The KADCYLA logo comes in one version: a logo. Download as transparent PNG.
What are KADCYLA's brand colors?
The KADCYLA color palette uses the hex codes #565656, #FFFFFF and #692027.
The KADCYLA name, logos and brand assets are trademarks of KADCYLA and its affiliates. Brandfetch isn't affiliated with or endorsed by KADCYLA. Their use is subject to KADCYLA's brand guidelines.
